Study of Venetoclax in Combination With Carfilzomib and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma (MM)

What's the purpose of this trial?

A Phase 2, open-label, dose escalation study to evaluate the safety and efficacy of venetoclax in combination with carfilzomib-dexamethasone (Kd) in participants with relapsed or refractory MM and have received at least 1 prior line of therapy.

This trial is currently open and accepting patients.

What will happen during the trial?

Additional Trial Information

Phase 2

Enrollment: 120 patients (estimated)

View More

Trial Locations

All Trial Locations

View all clinical trial locations sorted by state.


UAB Comprehensive Cancer Center University of Alabama at Birmingham

Birmingham, AL

Open and Accepting


University of Arkansas for Medical Sciences (UAMS)

Little Rock, AR

Open and Accepting


Marin Cancer Care

Greenbrae, CA

Not Yet Accepting


Memorial Cancer Institute Memorial Regional Hospital

Hollywood, FL

Open and Accepting


Winship Cancer Institute of Emory University

Atlanta, GA

Open and Accepting


University of Chicago Medicine Comprehensive Cancer Center

Chicago, IL

Open and Accepting


Blood and Marrow Transplantation Franciscan Health

Indianapolis, IN

Open and Accepting


Central Maine Medical Center

Lewiston, ME

Open and Accepting



Alvin J. Siteman Cancer Center Washington University Medical Campus

St. Louis, MO

Open and Accepting

Oncology Hematology Associates (OHA)

Springfield, MO

Open and Accepting

North Carolina

Carolinas Medical Center

Charlotte, NC

Not Yet Accepting

Duke Cancer Center Duke University Medical Center

Durham, NC

Open and Accepting


Abramson Cancer Center University of Pennsylvania

Philadelphia, PA

Open and Accepting


Baylor Scott & White Hospital

Temple, TX

Open and Accepting


Huntsman Cancer Institute University of Utah

Salt Lake City, UT

Open and Accepting


VA Puget Sound Health Care System

Seattle, WA

Open and Accepting


Aurora Research Institute

Wauwatosa, WI

Open and Accepting
Interested in this trial?
  • Call us today 😀 keyboard_arrow_right

    We know how difficult and confusing this process can be. If you are interested in this clinical trial or have questions, you can call us at any time. You can also send us a direct message with questions.

    (888) 828-2206
  • If you are interested in keeping an eye on this trial, you can add it to your list of favorite trials. We'll send you alerts when this trial is updated.

  • Talk to your doctor keyboard_arrow_right

    You can print an overview of this trial to take in to your next appointment. Your doctor can help you understand if this trial may be right for you.

Still need help? Send us a message

SparkCures Verified

SparkCures is working closely with AbbVie to provide the most up-to-date information on this clinical trial. Use the button above to add this trial to your list of favorites.

Learn more about how we work with trial sponsors